Menu

Private Payer Telehealth Coverage During the COVID-19 Pandemic

PHI’s Center for Connected Health Policy’s staff analyzed coverage policies and bulletins for the largest U.S. private payers and summarized the findings in this report, Private Payer Telehealth Coverage During the COVID-19 Pandemic.

Privat Payer Telehealth Coverage During the Public Health Emergency

The COVID-19 pandemic has placed a renewed focus on the United States’ insurance-based health care system. PHI’s Center for Connected Health Policy’s staff analyzed coverage policies and bulletins for the largest U.S. private payers and summarized the findings in this report, Private Payer Telehealth Coverage During the COVID-19 Pandemic.

In March 2020, the largest U.S. health insurers announced that they would waive cost-sharing obligations for COVID-19 tests and treatment, including for telehealth visits. This signaled a different approach from America’s health insurance industry in combating the spread of the virus. What followed was a series of temporary and, in some cases, permanent changes to payer’s telehealth coverage policies.

The report builds on CCHP’s COVID-19 research and resources by detailing the efforts that major U.S. health insurance carriers took to expand telehealth access in response to the pandemic. The eligibility windows for these policy changes ranged from March 2020 through the end of the public health emergency (PHE). CCHP focused the analysis on private payer policies that were implemented prior to November 25, 2020.

Download the Report

Key Findings

  1. All of the national insurance carriers voluntarily expanded telehealth coverage for their commercial health plans on a temporary basis during the PHE.
  2. Nearly all major insurers (6 of 7) waived cost-sharing for COVID-19 telehealth treatment services and also for non-COVID primary or urgent care telehealth visits.
  3. Four major insurers agreed to cover limited out-of-network telehealth services, with at least 1 major payer (Anthem Blue Cross Blue Shield) waiving cost share obligations for out-of-network telemedicine visits through Spring 2020.
  4. Six major payers agreed to reimburse providers at the in-person rate, including for audio-only services.
  5. The majority of these expansions expired by the end of 2020, while a limited number of payers aligned expiration with the end of the PHE.

Originally published by Center for Connected Health Policy


Work With Us

You change the world. We do the rest. Explore fiscal sponsorship at PHI.

Bring Your Work to PHI

Support Us

Together, we can accelerate our response to public health’s most critical issues.

Donate

Find Employment

Begin your career at the Public Health Institute.

See Jobs

Emergency room nurse talks with patient

Close

New Study: ED Buprenorphine Linked to Sustained Opioid Use Disorder Treatment

Patients who get their first dose of buprenorphine in the Emergency Department (ED) are more likely to remain engaged in opioid use disorder treatment 30 days post-discharge, finds a new study from PHI's CA Bridge—reinforcing EDs as critical access points to highly effective, life-saving medication for addiction treatment.

read the study

Continue to PHI.org